Global phenotypic screening for antimalarials.

Area of Science:

• Infectious Diseases
• Drug Discovery
• Parasitology

Background:

• Malaria, caused by Plasmodium spp., results in approximately 655,000 deaths annually, predominantly affecting African children.
• Emerging drug resistance to existing antimalarials, including artemisinin-based therapies, necessitates the development of novel treatments.
• The need for new antimalarials with distinct mechanisms of action is critical.

Purpose of the Study:

• To review and characterize compounds identified through phenotypic screening for inhibiting Plasmodium falciparum blood-stage growth.
• To explore current strategies for developing these identified compounds into viable drug leads.
• To advocate for a
• Main_Methods
• Main_Results
• Conclusions

Main Methods:

• Phenotypic screening campaigns were conducted to identify compounds inhibiting Plasmodium falciparum growth.
• Characterization of identified active compounds was performed.
• Strategies for lead molecule development were explored.

Main Results:

• Multiple compounds were identified through phenotypic screening.
• Characterization data for these compounds are described.
• Ongoing strategies for lead optimization are discussed.

Conclusions:

• The identified compounds represent promising starting points for new antimalarial drug development.
• A
• malaria box
• of publicly accessible active compounds is proposed to accelerate research.
• Novel antimalarials are crucial to overcome drug resistance in Plasmodium falciparum infections.